Contraception use and HIV outcomes among women initiating dolutegravir‐containing antiretroviral therapy in Kenya: a retrospective cohort study-Reference-Cited by-同舟云学术

Contraception use and HIV outcomes among women initiating dolutegravir‐containing antiretroviral therapy in Kenya: a retrospective cohort study

Author:

Humphrey John M.¹^ORCID,Omodi Victor²,Bernard Caitlin³^ORCID,Maina Mercy²,Thorne Julie⁴,Mwangi Ann⁵,Wools‐Kaloustian Kara¹,Patel Rena C.⁶^ORCID

Affiliation:

1. Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA

2. Academic Model Providing Access to Healthcare (AMPATH) Eldoret Kenya

3. Department of Obstetrics and Gynecology Indiana University School of Medicine Indianapolis Indiana USA

4. Department of Obstetrics and Gynecology University of Toronto Toronto Ontario Canada

5. Department of Behavioural Science School of Medicine Moi University Eldoret Kenya

6. Departments of Medicine and Global Health Washington University Seattle Washington USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

Reference38 articles.

3. European Medicines Agency. New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir.Amsterdam;2018.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献